Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

248.68
+1.170.47%
Post-market: 250.001.32+0.53%19:30 EDT
Volume:1.18M
Turnover:294.98M
Market Cap:33.18B
PE:44.25
High:254.08
Open:248.05
Low:246.01
Close:247.51
52wk High:495.55
52wk Low:197.81
Shares:133.43M
Float Shares:133.16M
Volume Ratio:0.72
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.62
EPS(LYR):2.33
ROE:96.55%
ROA:12.34%
PB:24.50
PE(LYR):106.73

Loading ...

Jun 18, 2025

Major Issues Report

Form 8-K - Current report
Jun 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 22, 2025

Correspondence

Form CORRESP - Correspondence
May 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 13, 2025

Major Issues Report

Form 8-K - Current report
May 01, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2025

Major Issues Report

Form 8-K - Current report
Mar 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 21, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities